Chromosome 22q11.2 deletion syndrome, distal
diseaseOn this page
Also known as distal 22q11.2 microdeletion syndromedistal del(22)(q11.2)distal monosomy 22q11.2
Summary
Chromosome 22q11.2 deletion syndrome, distal (MONDO:0012740) is a disease with 10 cohort genes.
At a glance
- Prevalence: Unknown (Worldwide)
- Cohort genes: 10
- ClinVar variants: 13
- Phenotypes (HPO): 60
Clinical features
Signs & symptoms
Clinical features (HPO)
60 HPO clinical features (Orphanet curated; top 50 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000319 | Smooth philtrum | Very frequent (80-99%) |
| HP:0001249 | Intellectual disability | Very frequent (80-99%) |
| HP:0001263 | Global developmental delay | Very frequent (80-99%) |
| HP:0001622 | Premature birth | Very frequent (80-99%) |
| HP:0002463 | Language impairment | Very frequent (80-99%) |
| HP:0002553 | Highly arched eyebrow | Very frequent (80-99%) |
| HP:0004322 | Short stature | Very frequent (80-99%) |
| HP:0000219 | Thin upper lip vermilion | Frequent (30-79%) |
| HP:0000252 | Microcephaly | Frequent (30-79%) |
| HP:0000307 | Pointed chin | Frequent (30-79%) |
| HP:0000363 | Abnormality of earlobe | Frequent (30-79%) |
| HP:0000430 | Underdeveloped nasal alae | Frequent (30-79%) |
| HP:0000490 | Deeply set eye | Frequent (30-79%) |
| HP:0001511 | Intrauterine growth retardation | Frequent (30-79%) |
| HP:0001660 | Truncus arteriosus | Frequent (30-79%) |
| HP:0001763 | Pes planus | Frequent (30-79%) |
| HP:0001802 | Absent toenail | Frequent (30-79%) |
| HP:0001817 | Absent fingernail | Frequent (30-79%) |
| HP:0002664 | Neoplasm | Frequent (30-79%) |
| HP:0004209 | Clinodactyly of the 5th finger | Frequent (30-79%) |
| HP:0000010 | Recurrent urinary tract infections | Occasional (5-29%) |
| HP:0000023 | Inguinal hernia | Occasional (5-29%) |
| HP:0000160 | Narrow mouth | Occasional (5-29%) |
| HP:0000175 | Cleft palate | Occasional (5-29%) |
| HP:0000272 | Malar flattening | Occasional (5-29%) |
| HP:0000276 | Long face | Occasional (5-29%) |
| HP:0000324 | Facial asymmetry | Occasional (5-29%) |
| HP:0000407 | Sensorineural hearing impairment | Occasional (5-29%) |
| HP:0000426 | Prominent nasal bridge | Occasional (5-29%) |
| HP:0000453 | Choanal atresia | Occasional (5-29%) |
| HP:0000581 | Blepharophimosis | Occasional (5-29%) |
| HP:0000657 | Oculomotor apraxia | Occasional (5-29%) |
| HP:0000716 | Depression | Occasional (5-29%) |
| HP:0000722 | Compulsive behaviors | Occasional (5-29%) |
| HP:0001166 | Arachnodactyly | Occasional (5-29%) |
| HP:0001250 | Seizure | Occasional (5-29%) |
| HP:0001510 | Growth delay | Occasional (5-29%) |
| HP:0001629 | Ventricular septal defect | Occasional (5-29%) |
| HP:0001631 | Atrial septal defect | Occasional (5-29%) |
| HP:0001659 | Aortic regurgitation | Occasional (5-29%) |
| HP:0001770 | Toe syndactyly | Occasional (5-29%) |
| HP:0001852 | Sandal gap | Occasional (5-29%) |
| HP:0002021 | Pyloric stenosis | Occasional (5-29%) |
| HP:0002205 | Recurrent respiratory infections | Occasional (5-29%) |
| HP:0002607 | Bowel incontinence | Occasional (5-29%) |
| HP:0002673 | Coxa valga | Occasional (5-29%) |
| HP:0002705 | High, narrow palate | Occasional (5-29%) |
| HP:0002721 | Immunodeficiency | Occasional (5-29%) |
| HP:0003307 | Hyperlordosis | Occasional (5-29%) |
| HP:0004279 | Short palm | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | chromosome 22q11.2 deletion syndrome, distal |
| Mondo ID | MONDO:0012740 |
| MeSH | C567511 |
| OMIM | 611867 |
| Orphanet | 261330 |
| DOID | DOID:0060413 |
| SNOMED CT | 734029004 |
| UMLS | C2678480 |
| MedGen | 395634 |
| GARD | 0017245 |
| Is cancer (heuristic) | no |
Also known as: chromosome 22q11.2 deletion syndrome, distal · distal 22q11.2 microdeletion syndrome · distal del(22)(q11.2) · distal monosomy 22q11.2
Data availability: 13 ClinVar variants.
Disease family
Classification path: disease › human disease › disease by body system or component › nervous system disorder › congenital nervous system disorder › 22q11.2 deletion syndrome › chromosome 22q11.2 deletion syndrome, distal
Related subtypes (3): congenital unilateral hypoplasia of depressor anguli oris, DiGeorge syndrome, velocardiofacial syndrome
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
13 retrieved; paginated sample, class counts are floors:
11 pathogenic, 1 uncertain significance, 1 likely pathogenic
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 4820242 | Single allele | AIFM3 | Pathogenic | criteria provided, single submitter |
| 599193 | NC_000022.10:g.21808950_22963000del1154051 | CCDC116 | Pathogenic | criteria provided, single submitter |
| 830215 | NC_000022.10:g.(21822774_21914652)_(22922798_23025613)del | CCDC116 | Pathogenic | criteria provided, single submitter |
| 1330197 | GRCh37/hg19 22q11.21(chr22:18660135-21737597)x1 | DGCR6 | Pathogenic | criteria provided, single submitter |
| 625626 | GRCh37/hg19 22q11.21-11.23(chr22:21797384-23630313) | IGLC1 | Pathogenic | criteria provided, single submitter |
| 2580309 | GRCh37/hg19 22q11.21(chr22:18893838-21416074)x3 | KLHL22 | Pathogenic | criteria provided, single submitter |
| 2580299 | GRCh37/hg19 22q11.21(chr22:20609932-21576553)x1 | LZTR1 | Pathogenic | criteria provided, single submitter |
| 1703235 | Single allele | MRPL40 | Pathogenic | criteria provided, single submitter |
| 2580291 | GRCh37/hg19 22q11.21(chr22:18893838-20508931)x3 | MRPL40 | Pathogenic | criteria provided, single submitter |
| 2663782 | NC_000022.10:g.(?21797384)(23630313_?)del | PRAME | Pathogenic | criteria provided, single submitter |
| 973580 | NC_000022.10:g.21514655_22986816del | RIMBP3B | Pathogenic | criteria provided, single submitter |
| 3384223 | GRCh37/hg19 22q11.22-11.23(chr22:22989174-23657759)x1 | IGLC1 | Likely pathogenic | no assertion criteria provided |
| 1339957 | NM_001089.3(ABCA3):c.4868C>T (p.Ala1623Val) | ABCA3 | Uncertain significance | criteria provided, multiple submitters, no conflicts |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 0 · Orphanet: 9 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| ABCA3 | Orphanet:2032 | Idiopathic pulmonary fibrosis |
| ABCA3 | Orphanet:217563 | Neonatal acute respiratory distress syndrome |
| ABCA3 | Orphanet:440402 | Interstitial lung disease due to ABCA3 deficiency |
| ABCA3 | Orphanet:685082 | Pediatric acute respiratory distress syndrome |
| LZTR1 | Orphanet:251576 | Gliosarcoma |
| LZTR1 | Orphanet:251579 | Giant cell glioblastoma |
| LZTR1 | Orphanet:2678 | Familial isolated café-au-lait macules |
| LZTR1 | Orphanet:648 | Noonan syndrome |
| LZTR1 | Orphanet:93921 | Full schwannomatosis |
Cohort genes → proteins
10 cohort genes, 10 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 10 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| MRPL40 | HGNC:14491 | ENSG00000185608 | Q9NQ50 | Large ribosomal subunit protein mL40 | clinvar |
| KLHL22 | HGNC:25888 | ENSG00000099910 | Q53GT1 | Kelch-like protein 22 | clinvar |
| AIFM3 | HGNC:26398 | ENSG00000183773 | Q96NN9 | Apoptosis-inducing factor 3 | clinvar |
| CCDC116 | HGNC:26688 | ENSG00000161180 | Q8IYX3 | Coiled-coil domain-containing protein 116 | clinvar |
| DGCR6 | HGNC:2846 | ENSG00000183628 | Q14129 | Protein DGCR6 | clinvar |
| ABCA3 | HGNC:33 | ENSG00000167972 | Q99758 | Phospholipid-transporting ATPase ABCA3 | clinvar |
| RIMBP3B | HGNC:33891 | ENSG00000274600 | A6NNM3 | RIMS-binding protein 3B | clinvar |
| IGLC1 | HGNC:5855 | ENSG00000211675 | P0CG04 | Immunoglobulin lambda constant 1 | clinvar |
| LZTR1 | HGNC:6742 | ENSG00000099949 | Q8N653 | Leucine-zipper-like transcriptional regulator 1 | clinvar |
| PRAME | HGNC:9336 | ENSG00000185686 | P78395 | Melanoma antigen preferentially expressed in tumors | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| KLHL22 | Kelch-like protein 22 | Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex required for chromosome alignment and localization of PLK1 at kinetochores. |
| AIFM3 | Apoptosis-inducing factor 3 | Induces apoptosis through a caspase dependent pathway. |
| DGCR6 | Protein DGCR6 | May play a role in neural crest cell migration into the third and fourth pharyngeal pouches. |
| ABCA3 | Phospholipid-transporting ATPase ABCA3 | Catalyzes the ATP-dependent transport of phospholipids such as phosphatidylcholine and phosphoglycerol from the cytoplasm into the lumen side of lamellar bodies, in turn participates in the lamellar bodies biogenesis and homeostasis of pul… |
| RIMBP3B | RIMS-binding protein 3B | Probable component of the manchette, a microtubule-based structure which plays a key role in sperm head morphogenesis during late stages of sperm development. |
| IGLC1 | Immunoglobulin lambda constant 1 | Constant region of immunoglobulin light chains. |
| LZTR1 | Leucine-zipper-like transcriptional regulator 1 | Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates ubiquitination of Ras (K-Ras/KRAS, N-Ras/NRAS and H-Ras/HRAS). |
| PRAME | Melanoma antigen preferentially expressed in tumors | Substrate-recognition component of a Cul2-RING (CRL2) E3 ubiquitin-protein ligase complex, which mediates ubiquitination of target proteins, leading to their degradation. |
Protein-family classification
Druggable: 3 · Difficult: 0 · Unknown: 7 · Druggable fraction: 0.3
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Antibody/Immunoglobulin | 2 | 5.8× | 0.132 |
| Transporter | 1 | 7.8× | 0.182 |
| Other/Unknown | 7 | 1.2× | 0.284 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| MRPL40 | Other/Unknown | no | Ribosomal_mL40, Ribosomal_mL40_metazoa/plant | |
| KLHL22 | Other/Unknown | no | BTB/POZ_dom, Kelch_1, SKP1/BTB/POZ_sf | |
| AIFM3 | Other/Unknown | no | FAD/NAD-linked_Rdtase_dimer_sf, Rieske_2Fe-2S, FAD/NAD-binding_dom | |
| CCDC116 | Other/Unknown | no | DUF4702 | |
| DGCR6 | Other/Unknown | no | Gonadal | |
| ABCA3 | Transporter | yes | ABC_transporter-like_ATP-bd, AAA+_ATPase, ABC2_TM | |
| RIMBP3B | Antibody/Immunoglobulin | yes | SH3_domain, FN3_dom, Ig-like_fold | |
| IGLC1 | Antibody/Immunoglobulin | yes | Ig/MHC_CS, Ig_C1-set, Ig-like_dom | |
| LZTR1 | Other/Unknown | no | BTB/POZ_dom, Kelch_1, SKP1/BTB/POZ_sf | |
| PRAME | Other/Unknown | no | PRAME, LRR_dom_sf, LRRC14/PRAME |
Expression context
Cohort genes with no expression data: 0.
8 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 10 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| left testis | 3 |
| right hemisphere of cerebellum | 2 |
| mucosa of transverse colon | 2 |
| male germ line stem cell (sensu Vertebrata) in testis | 2 |
| right testis | 2 |
| testis | 2 |
| biceps brachii | 1 |
| heart right ventricle | 1 |
| skeletal muscle tissue of rectus abdominis | 1 |
| cerebellar cortex | 1 |
| cerebellar hemisphere | 1 |
| right frontal lobe | 1 |
| gastrocnemius | 1 |
| hindlimb stylopod muscle | 1 |
| skeletal muscle tissue | 1 |
| lower lobe of lung | 1 |
| upper lobe of left lung | 1 |
| upper lobe of lung | 1 |
| duodenum | 1 |
| rectum | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| MRPL40 | 292 | ubiquitous | marker | skeletal muscle tissue of rectus abdominis, biceps brachii, heart right ventricle |
| KLHL22 | 246 | ubiquitous | yes | right hemisphere of cerebellum, cerebellar hemisphere, cerebellar cortex |
| AIFM3 | 180 | tissue_specific | marker | mucosa of transverse colon, right frontal lobe, right hemisphere of cerebellum |
| CCDC116 | 146 | tissue_specific | yes | left testis, male germ line stem cell (sensu Vertebrata) in testis, right testis |
| DGCR6 | 134 | ubiquitous | marker | skeletal muscle tissue, hindlimb stylopod muscle, gastrocnemius |
| ABCA3 | 222 | ubiquitous | marker | lower lobe of lung, upper lobe of lung, upper lobe of left lung |
| RIMBP3B | 37 | marker | male germ line stem cell (sensu Vertebrata) in testis, left testis, testis | |
| IGLC1 | 126 | tissue_specific | marker | duodenum, rectum, mucosa of transverse colon |
| LZTR1 | 134 | ubiquitous | marker | sural nerve, pituitary gland, adenohypophysis |
| PRAME | 117 | broad | marker | right testis, left testis, testis |
Protein interactions among cohort
Intra-cohort edges: 4.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| MRPL40 | 2,393 |
| AIFM3 | 2,051 |
| PRAME | 1,804 |
| LZTR1 | 1,562 |
| ABCA3 | 1,436 |
| KLHL22 | 1,428 |
| CCDC116 | 633 |
| DGCR6 | 581 |
| RIMBP3B | 485 |
| IGLC1 | 18 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| AIFM3 | KLHL22 | string_interaction |
| AIFM3 | LZTR1 | biogrid_interaction, string_interaction |
| CCDC116 | RIMBP3B | string_interaction |
| DGCR6 | MRPL40 | string_interaction |
Structural data
PDB: 6 · AlphaFold-only: 4 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| MRPL40 | Q9NQ50 | 82 |
| AIFM3 | Q96NN9 | 7 |
| KLHL22 | Q53GT1 | 4 |
| IGLC1 | P0CG04 | 3 |
| LZTR1 | Q8N653 | 3 |
| ABCA3 | Q99758 | 2 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| DGCR6 | Q14129 | 86.83 |
| PRAME | P78395 | 81.29 |
| RIMBP3B | A6NNM3 | 59.08 |
| CCDC116 | Q8IYX3 | 50.59 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 24. Enrichment computed across 10 evidence-associated genes (3 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 3 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Defective ABCA3 causes SMDP3 | 1 | 3806.7× | 0.003 | ABCA3 |
| Metabolism of proteins | 3 | 12.4× | 0.004 | MRPL40, KLHL22, ABCA3 |
| Diseases associated with surfactant metabolism | 1 | 951.7× | 0.006 | ABCA3 |
| ABC transporters in lipid homeostasis | 1 | 200.3× | 0.024 | ABCA3 |
| ABC transporter disorders | 1 | 146.4× | 0.027 | ABCA3 |
| Surfactant metabolism | 1 | 122.8× | 0.028 | ABCA3 |
| Disorders of transmembrane transporters | 1 | 46.4× | 0.045 | ABCA3 |
| Mitochondrial translation | 1 | 45.9× | 0.045 | MRPL40 |
| Mitochondrial translation initiation | 1 | 42.3× | 0.045 | MRPL40 |
| Mitochondrial translation elongation | 1 | 42.3× | 0.045 | MRPL40 |
| Mitochondrial ribosome-associated quality control | 1 | 40.9× | 0.045 | MRPL40 |
| ABC-family protein mediated transport | 1 | 40.5× | 0.045 | ABCA3 |
| Mitochondrial translation termination | 1 | 36.6× | 0.046 | MRPL40 |
| Diseases of metabolism | 1 | 26.8× | 0.059 | ABCA3 |
| Class I MHC mediated antigen processing & presentation | 1 | 23.4× | 0.063 | KLHL22 |
| Translation | 1 | 20.7× | 0.067 | MRPL40 |
| Neddylation | 1 | 15.8× | 0.083 | KLHL22 |
| Antigen processing: Ubiquitination & Proteasome degradation | 1 | 12.4× | 0.099 | KLHL22 |
| Adaptive Immune System | 1 | 9.9× | 0.117 | KLHL22 |
| Transport of small molecules | 1 | 8.4× | 0.131 | ABCA3 |
| Post-translational protein modification | 1 | 6.4× | 0.162 | KLHL22 |
| Disease | 1 | 4.4× | 0.214 | ABCA3 |
| Immune System | 1 | 4.3× | 0.214 | KLHL22 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 9 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| positive regulation of protein homooligomerization | 1 | 1872.4× | 0.025 | ABCA3 |
| regulation of phosphatidylcholine metabolic process | 1 | 936.2× | 0.025 | ABCA3 |
| xenobiotic export from cell | 1 | 624.1× | 0.025 | ABCA3 |
| positive regulation of phospholipid efflux | 1 | 468.1× | 0.025 | ABCA3 |
| regulation of lipid biosynthetic process | 1 | 312.1× | 0.025 | ABCA3 |
| organelle assembly | 1 | 312.1× | 0.025 | ABCA3 |
| positive regulation of T cell mediated immune response to tumor cell | 1 | 267.5× | 0.025 | KLHL22 |
| positive regulation of phospholipid transport | 1 | 267.5× | 0.025 | ABCA3 |
| negative regulation of retinoic acid receptor signaling pathway | 1 | 170.2× | 0.031 | PRAME |
| phosphatidylglycerol metabolic process | 1 | 156.0× | 0.031 | ABCA3 |
| cellular response to L-leucine | 1 | 156.0× | 0.031 | KLHL22 |
| phospholipid homeostasis | 1 | 110.1× | 0.034 | ABCA3 |
| xenobiotic transmembrane transport | 1 | 104.0× | 0.034 | ABCA3 |
| xenobiotic transport | 1 | 93.6× | 0.034 | ABCA3 |
| surfactant homeostasis | 1 | 89.2× | 0.034 | ABCA3 |
| phosphatidylcholine metabolic process | 1 | 89.2× | 0.034 | ABCA3 |
| execution phase of apoptosis | 1 | 85.1× | 0.034 | AIFM3 |
| phospholipid transport | 1 | 78.0× | 0.034 | ABCA3 |
| immunoglobulin mediated immune response | 1 | 78.0× | 0.034 | IGLC1 |
| negative regulation of Ras protein signal transduction | 1 | 74.9× | 0.034 | LZTR1 |
| proteasome-mediated ubiquitin-dependent protein catabolic process | 2 | 11.6× | 0.034 | KLHL22, PRAME |
| positive regulation of cholesterol efflux | 1 | 69.3× | 0.035 | ABCA3 |
| mitotic spindle assembly checkpoint signaling | 1 | 62.4× | 0.037 | KLHL22 |
| negative regulation of type I interferon production | 1 | 55.1× | 0.040 | KLHL22 |
| mitotic sister chromatid segregation | 1 | 53.5× | 0.040 | KLHL22 |
| positive regulation of T cell activation | 1 | 49.3× | 0.042 | KLHL22 |
| B cell receptor signaling pathway | 1 | 44.6× | 0.044 | IGLC1 |
| protein monoubiquitination | 1 | 38.2× | 0.050 | KLHL22 |
| response to glucocorticoid | 1 | 36.0× | 0.051 | ABCA3 |
| fertilization | 1 | 34.7× | 0.051 | RIMBP3B |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 10
Druggability breadth: 0 of 10 evidence-associated genes (0%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| MRPL40 | 0 | 0 |
| KLHL22 | 0 | 0 |
| AIFM3 | 0 | 0 |
| CCDC116 | 0 | 0 |
| DGCR6 | 0 | 0 |
| ABCA3 | 0 | 0 |
| RIMBP3B | 0 | 0 |
| IGLC1 | 0 | 0 |
| LZTR1 | 0 | 0 |
| PRAME | 0 | 0 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 0.
Pharmacogenomics
Cohort genes with a PharmGKB record: 10; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 2 | ABCA3, IGLC1 |
| D | Druggable family + AlphaFold only, no drug | 1 | RIMBP3B |
| E | Difficult family or no structure, no drug | 7 | MRPL40, KLHL22, AIFM3, CCDC116, DGCR6, LZTR1, PRAME |
Undrugged target profiles
10 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| MRPL40 | 0 | — |
| KLHL22 | 0 | — |
| AIFM3 | 0 | — |
| CCDC116 | 0 | — |
| DGCR6 | 0 | — |
| ABCA3 | 0 | — |
| RIMBP3B | 0 | — |
| IGLC1 | 0 | — |
| LZTR1 | 0 | — |
| PRAME | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.